Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Study on Efficacy and Safety of CBLB612 for Neutropenia Prophylaxis
- First Posted Date
- 2016-05-20
- Last Posted Date
- 2016-07-20
- Lead Sponsor
- BioLab 612 LLC
- Target Recruit Count
- 23
- Registration Number
- NCT02778763
Clinical Study of Safety and Tolerability of CBLB502 as a Neo-adjuvant Treatment in Patients With Colorectal Cancer
- First Posted Date
- 2016-03-22
- Last Posted Date
- 2017-02-09
- Lead Sponsor
- BioLab 612 LLC
- Target Recruit Count
- 40
- Registration Number
- NCT02715882
- Locations
- 🇷🇺
Federal State Budgetary Institution "State Scientific Center of Coloproctology named after A.N. Ryzhikh" Ministry of Health of the Russian Federation, Moscow, Russian Federation
News
No news found